Driving Innovation
in Clinical Trials
Together
Empowering Life Sciences Leaders to Redefine Clinical Trial Success
00
DAYS00
HOURS00
MINUTES00
SECONDSEvent Agenda
Explore two days of insightful sessions, keynote presentations, and networking opportunities designed to advance clinical trials innovation.
Welcome Reception & Networking
Start your day with coffee, light breakfast, and networking with fellow attendees, speakers, and sponsors in the exhibition hall.
Summits Connect Team
Event Hosts
The Future of Clinical Trials: 2030 and Beyond
Visionary insights into how AI, decentralized trials, and patient-centric models will transform clinical research in the coming decade.
Dr. James Dawson
Chief Innovation Officer, Global Pharma
Maria Rodriguez
Director, FDA Center for Drug Evaluation
Overcoming Global Clinical Trial Challenges
Leaders from pharma, CROs, and regulatory bodies discuss solutions for patient recruitment, data interoperability, and regulatory harmonization.
Dr. Sarah Khan
VP Clinical Operations, BioGenix
Thomas Parker
CEO, InnovateCRO
Dr. Lisa Wang
Regulatory Affairs Director, EMA
Networking Lunch & Technology Showcase
Explore cutting-edge solutions in the exhibition hall while enjoying lunch. Featuring demo zones for AI platforms, eClinical tools, and patient engagement technologies.
Digital Transformation in Clinical Research
Parallel tracks focusing on: 1) Implementing decentralized trial models, 2) AI for patient matching, 3) Real-world evidence integration.
Dr. Alex Rivera
CTO, TrialTech Solutions
Emma Kim
Head of Digital Health, PharmaCorp
Day 1 Wrap-up & Evening Reception
Summary of key insights followed by cocktail reception in the exhibition hall with live music and networking opportunities.
Networking Breakfast
Start Day 2 with coffee and breakfast while connecting with new contacts from Day 1 and exploring additional exhibition booths.
Patient-Centric Trials: From Theory to Practice
Exploring successful implementations of patient-centered approaches and measuring their impact on trial outcomes and patient experiences.
Dr. Priya Thompson
Patient Advocacy Director, HealthTech Global
Michael Stevens
Clinical Trial Participant & Advocate
Implementing AI in Clinical Operations
Hands-on session exploring AI tools for protocol optimization, site selection, and risk-based monitoring with live demonstrations.
Dr. David Chen
AI Research Lead, ClinicalAI Labs
Rachel Green
Operations Director, Precision Trials
Themed Networking Lunch
Join topic-specific roundtables: 1) Rare disease trials, 2) Oncology trials innovation, 3) Pediatric research, 4) Digital endpoints.
Regulatory Pathways for Digital Therapeutics
Regulatory experts discuss evolving frameworks for digital health technologies, real-world evidence, and adaptive trial designs.
Dr. Kenji Kato
Senior Reviewer, PMDA Japan
Elena Hernandez
Digital Health Lead, Health Canada
Robert Singh
VP Regulatory Strategy, MedTech Innovations
Shaping the Future Together: Actionable Insights
Synthesizing key takeaways and establishing collaborative initiatives for advancing clinical trials innovation in the coming year.
Dr. James Dawson
Chief Innovation Officer, Global Pharma
Maria Rodriguez
Director, FDA Center for Drug Evaluation
Dr. Sarah Khan
VP Clinical Operations, BioGenix
Farewell Reception & Networking
Final networking opportunity with drinks and canapés. Collect conference materials and connect with speakers and peers before departure.
Future-Ready Speakers
Industry leaders shaping the future of clinical trials.
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Xing Li
Founder & Chief Executive Officer
Deep Intelligent Pharma
Veronika Jotterand
Medical Director, Global Clinical Development
MSD
Aleksandra Moniuszko
Director Risk Based Quality Management
AstraZeneca
Kingsley Kaluarachchi
Leader, Clinical Risk Management and Process Excellence
GE HealthCare
Puja Myles
Director, Clinical Practice Research Datalink
Medicines and Healthcare products Regulatory Agency
Krunal Shah
Associate Director, Study Delivery Lead
GSK
Alina Pszczolkowska
Head of Excellence, Global Medical Evidence
AstraZeneca
Andrea Manfrin
Deputy Director, Clinical Investigations and Trials
Medicines and Healthcare products Regulatory Agency
Fiona Shields
Study and Site Operations Country Head (UK)
Novartis
Anna Zarodkiewicz
Director Centralized Monitoring
AstraZeneca
Tina Barton
Chief Operating Officer
eMQT
Gail Kemp
Senior Director
Novo Nordisk
Samu Kurki
Strategic Project Lead
Bayer Pharmaceuticals
Kirsty Sweeney
Associate Director, Global Clinical Site Contracting
GSK
Mario Alfiero
Director Site Management & Monitoring
AstraZeneca
Sarah Deeley
Director, Country & Site Operations
Biogen
Laura Risueno Ayerbe
Global Patient Affairs, Patient Engagement R&D
Servier
Judit Magos
Clinical Operations Manager
Viatris
Aina Viladot
Associate Director, Global Clinical Quality and Performance
AstraZeneca
Marieangela Economopoulou
Head of External Affairs and Patient Value Access
Takeda
Shalom Lloyd
Co-Founder & Chief Strategy Officer
eMQT
Rafik Fellague-Chebra
Executive Global Group Medical Director, Solid tumors, GI cancers
Novartis Oncology
Clara Cali Mella
Data Strategy Lead
Bayer
Arijit Patra
Senior Principal Scientist
UCB
Paula Walker
Global Head Risk Based Quality Management
Roche
Mihaela Nosca
Director Clinical Compliance and Inspection Readiness
CSL Seqirus
Rebecca Jackson
Associate Director, Global Development Systems
Johnson & Johnson Innovative Medicine
Vesela Aleksandrova
Clinical Oversight and Strategy Director
Shionogi Europe
Lucy Sherborne
Site engagement lead
Sanofi
Giorgos Cheliotis
Associate Director Clinical processes & Solutions
Novartis
Jonathan Crowther
Head, Operational Design Center
Merck Healthcare
Kayuri Odedra
Associate Director Patient Advocacy
Alexion Pharmaceuticals
Emily Pickering
Patient Engagement in Clinical Development Service Lead
NIHR Research Delivery Network
Volodymyr Anisimov
Data Science Director | Centre for Design & Analysis
Amgen
Aedan Martin
Global Information & Technology Business Partner
Roche
